Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JD-RISE: JDB0131 benzenesulfonate versus delamanid regimens in rifampicin-resistant pulmonary tuberculosis
CTR20253474Phase 2Active
- Sponsor
- Jumbo Drug Bank
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JDB0131 in Rifampicin-resistant pulmonary tuberculosis (RR-PTB), sponsored by Jumbo Drug Bank. Started Sep 2025; status: active.
02
Drugs
JDB0131
03
Conditions
Rifampicin-resistant pulmonary tuberculosis (RR-PTB)
Beyond the preview
Go deeper on CTR20253474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253474.